Rivaroxaban is an oral anticoagulant medication that is used to prevent and treat blood clots in various medical conditions. It is a member of the direct oral anticoagulant (DOAC) class of drugs and is commonly marketed under the brand name Xarelto. As of my last knowledge update in January 2022, Rivaroxaban had a significant presence […]
Report Summary: The report provides an overview of the Rivaroxaban market, focusing on its usage as an anticoagulant medication. Rivaroxaban, marketed under the brand name Xarelto, is widely used for the prevention and treatment of blood clots, including deep vein thrombosis, pulmonary embolism, and stroke in patients with atrial fibrillation. The report highlights that Rivaroxaban offers […]